CD117: A Protein with Potential for Treating A Variety of Diseases

Target Name: CCDC117

NCBI ID: G150275

CCDC117

CD117: A Protein with Potential for Treating A Variety of Diseases

CCDC117 (CC117_HUMAN), also known as CD117, is a protein that is expressed in various tissues of the human body, including the skin, hair, and nails. It is a member of the CD117 family of cytokine-presented proteins, which are known for their ability to interact with and stimulate the activity of T cells, a type of immune cell that plays a crucial role in fighting off infections and diseases.

One of the unique features of CCDC117 is its ability to be targeted by drugs. This is because of its expression in various tissues, which makes it an attractive target for researchers and pharmaceutical companies looking for new treatments for a variety of diseases.

CDC117 has been shown to play a role in a number of different diseases and conditions, including cancer, autoimmune disorders, and skin infections. For example, studies have shown that high levels of CCDC117 are associated with an increased risk of cancer, particularly breast cancer. Additionally, CCDC117 has been shown to be involved in a number of autoimmune disorders, including rheumatoid arthritis and psoriasis.

In addition to its potential role in disease, CCDC117 has also been shown to be a potential drug target. Researchers have been exploring the use of drugs that can specifically target CCDC117 in order to treat various diseases. One of the most promising areas of research is the use of drugs that can target CCDC117 specifically, rather than its overall expression.

Targeting CCDC117 using drugs has the potential to be an effective way to treat a variety of diseases. Because CCDC117 is expressed in various tissues throughout the body, it is a potential target for drugs that can specifically target it in certain areas of the body. For example, drugs that can specifically target CCDC117 in the skin or hair may be effective in treating skin infections or hair loss. Additionally, drugs that can specifically target CCDC117 in certain tissues, such as cancer cells, may be effective in treating that specific type of cancer.

In conclusion, CCDC117 is a protein that has been shown to play a role in a number of different diseases and conditions. Its ability to be targeted by drugs makes it an attractive target for researchers and pharmaceutical companies looking for new treatments for a variety of diseases. As more research is done on CCDC117, it is likely that the potential uses for this protein will continue to grow and evolve.

Protein Name: Coiled-coil Domain Containing 117

Functions: Facilitates DNA repair, cell cycle progression, and cell proliferation through its interaction with CIAO2B

The "CCDC117 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC117 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets